Doximity reported strong Q3 performance, driven by high pharma client demand. Click here to find out why DOCS stock has been ...

Health and Human Services Secretary Robert F. Kennedy Jr. said any staffers in the department who are “working for the ...

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

After back-to-back years of 20%-plus gains in 2023 and 2024, the S&P 500 is off to another strong start to 2025. However, the S&P 500's forward earnings multiple of 22 (as of Feb. 7) was also ...

Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nineteen analysts that are covering the firm, Ratings reports. Eight research ...

In this process, royalty recipients often face the issue where multiple small future royalty streams cannot fulfill ongoing large lump-sum R&D funding needs. The mismatch is where Royalty Pharma ...

Achieving Universal Health Coverage (UHC) in Bangladesh remains a challenge due to the high out-of-pocket healthcare costs, particularly for medicines.

California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high.

Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company’s founder, president and CEO, will present virtually on Tuesday, February 18, 2025 at the Emerging Growth Conference.

As the demand for novel therapies and personalized medicine surges, leaders are uniquely positioned to create a culture of creativity, collaboration and innovation.

MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.